|
| |
| |
ARTICHOKE |
|
|
Hugh Sinclair Unit of Human Nutrition,
The University of Reading, UK.
A recent post-marketing study indicated
that high doses of standardised artichoke leaf extract (ALE)
may reduce symptoms of dyspepsia. To substantial these findings,
this study investigated the efficacy of a low-dose ALE on
amelioration of dyspeptic symptoms and improvement of quality
of life. The study was an open, dose-ranging postal study.
Healthy patients with self-reported dyspepsia were recruited
through the media. The Nepean Dyspepsia Index and the State-Trait
Anxiety Inventory were completed at baseline and after 2
months of treatment with ALE, which was randomly allocated
to volunteers as 320 or 640 mg daily. Of the 516 participants,
454 completed the study. In both dosage groups, compared
with baseline, there was a significant reduction of all
dyspeptic symptoms, with an average reduction of 40% in
global dyspepsia score. However, there were no differences
in the primary outcome measures between the two groups,
although relief of state anxiety, a secondary outcome, was
greater with the higher dosage (P = 0.03). Health-related
quality of life was significantly improved in both groups
compared with baseline. We conclude that ALE shows promise
to ameliorate upper gastro-intestinal symptoms and improve
quality of life in otherwise healthy subjects suffering
from dyspepsia.
|
|
|
The Hugh Sinclair Unit of Human Nutrition,
School of Food BioSciences, The University of Reading, PO
Box 226, Whiteknights, Reading RG6 6AP, UK.
Irritable bowel syndrome (IBS) is a problem
reported to affect 22% of the general population. It is
characterized by abdominal pain and altered bowel habit,
but has so far defied elucidation of its pathogenesis and
proved difficult to treat. There is a growing body of evidence
which indicates therapeutic properties for artichoke leaf
extract (ALE). Dyspepsia is the condition for which the
herb is specifically indicated, but the symptom overlap
between dyspeptic syndrome and IBS has given rise to the
notion that ALE may have potential for treating IBS as well.
A sub-group of patients with IBS symptoms was therefore
identified from a sample of individuals with dyspeptic syndrome
who were being monitored in a post-marketing surveillance
study of ALE for 6 weeks. Analysis of the data from the
IBS sub-group revealed significant reductions in the severity
of symptoms and favourable evaluations of overall effectiveness
by both physicians and patients. Furthermore, 96% of patients
rated ALE as better than or at least equal to previous therapies
administered for their symptoms, and the tolerability of
ALE was very good. These results provide support for the
notion that ALE has potential value in relieving IBS symptoms
and suggest that a controlled trial is justified.
|
|
|
Chair of Clinical Biochemistry and Laboratory
Diagnoastic, Regional Ctr. Atherosclerosis Research, Pomeranian
Academy of Medicine, ul. Powstancow Wlkp. 72, PL-70-111, Szczecin,
Poland.
It is currently believed that oxidative
stress and inflammation play a significant role in atherogenesis.
Artichoke extract exhibits hypolipemic properties and contains
numerous active substances with antioxidant properties in
vitro. We have studied the influence of aqueous and ethanolic
extracts from artichoke on intracellular oxidative stress
stimulated by inflammatory mediators (TNFalpha and LPS)
and ox-LDL in endothelial cells and monocytes. Oxidative
stress which reflects the intracellular production of reactive
oxygen species (ROS) was followed by measuring the oxidation
of 2', 7'-dichlorofluorescin (DCFH) to 2', 7'-dichlorofluorescein
(DCF). Agueous and ethanolic extracts from artichoke were
found to inhibit basal and stimulated ROS production in
endothelial cells and monocytes in dose dependent manner.
In endothelial cells, the ethanolic extract (50 microg/ml)
reduced ox-LDL-induced intracellular ROS production by 60%
(p<0,001) while aqueous extract (50 microg/ml) by 43%
(p<0,01). The ethanolic extract (50 microg/ml) reduced
ox-LDL-induced intracellular ROS production in monocytes
by 76% (p<0,01). Effective concentrations (25-100 microg/ml)
were well below the cytotoxic levels of the extracts which
started at 1 mg/ml as assessed by LDH leakage and trypan
blue exclusion. Penetration of some active substances into
the cells was necessary for inhibition to take place as
juged from the effect of preincubation time. These results
demonstrate that artichoke extracts have marked protective
properties against oxidative stress induced by inflammatory
mediators and ox-LDL in cultured endothelial cells and monocytes.
|
|
|
Department of Complementary Medicine,
University of Exeter, 25 Victoria Park Road, Exeter, Devon,
UK, EX2 4NT.
BACKGROUND: Hypercholesterolaemia is directly
associated with an increased risk for coronary heart disease
and other sequelae of atherosclerosis. Artichoke leaf extract
(ALE), which is available as an over-the-counter remedy,
has been implicated in lowering cholesterol levels. Whether
ALE is truly efficacious for this indication, however, is
still a matter of debate. OBJECTIVES: To assess the evidence
of ALE versus placebo or reference medication for treating
hypercholesterolaemia defined as mean total cholesterol
levels of at least 5.17 mmol/L (200 mg /dL). SEARCH STRATEGY:
We searched MEDLINE, Embase, Amed, Cinahl, CISCOM and the
Cochrane Controlled Trial Register. All databases were searched
from their respective inception until June 2001. Reference
lists of articles were also searched for relevant material.
Manufacturers of preparations containing artichoke extract
and experts on the subject were contacted and asked to contribute
published and unpublished material. SELECTION CRITERIA:
Randomized controlled trials of ALE mono-preparations compared
with placebo or reference medication for patients with hypercholesterolaemia
were included. Trials assessing ALE as one of several active
components in a combination preparation or as a part of
a combination treatment were excluded. DATA COLLECTION AND
ANALYSIS: Data were extracted systematically and methodological
quality was evaluated using a standard scoring system. The
screening of studies, selection, data extraction and the
assessment of methodological quality were performed independently
by two reviewers. Disagreements in the evaluation of individual
trials were resolved through discussion. MAIN RESULTS: Two
randomised trials including 167 participants met all inclusion
criteria. In one trial ALE reduced total cholesterol levels
from 7.74 mmol/l to 6.31 mmol/l after 42 +/- 3 days of treatment
whereas the placebo reduced cholesterol from 7.69 mmol/l
to 7.03 mmol/l (p=0.00001). Another trial did state that
ALE significantly (p<0.05) reduced blood cholesterol
compared with placebo in a sub-group of patients with baseline
total cholesterol levels of more than 230 mg/dl. Trial reports
and post-marketing surveillance studies indicate mild, transient
and infrequent adverse events. REVIEWER'S CONCLUSIONS: Few
data from rigorous clinical trials assessing ALE for treating
hypercholesterolaemia exist. Beneficial effects are reported,
the evidence however is not compelling. The limited data
on safety suggest only mild, transient and infrequent adverse
events with the short term use of ALE. More rigorous clinical
trials assessing larger patient samples over longer intervention
periods are needed to establish whether ALE is an effective
and safe treatment option for patients with hypercholesterolaemia.
|
|
ASPARAGUS |
|
|
Department of Pharmacology, Institute
of Medical Sciences, Banaras Hindu University, 221005, Varanasi,
India.
Asparagus racemosus is an Ayurvedic
rasayana, which finds mention in ancient Indian texts for
treatment of gastric ulcers. The ulcer protective effect of
methanolic extract of fresh roots of A. racemosus (ARM), 25-100mg/kg
given orally, twice daily for 5 days, was studied on different
gastroduodenal ulcer models. ARM 50mg/kg, twice daily, orally
(total saponins 0.9%) showed significant protection against
acute gastric ulcers induced by cold restraint stress (CRS),
pyloric ligation, aspirin plus pyloric ligation, and duodenal
ulcers induced by cysteamine. ARM in the above dose also significantly
healed chronic gastric ulcers induced by acetic acid after
10 days treatment. However, ARM was ineffective against aspirin-
and ethanol-induced gastric ulcers. Further, gastric juice
and mucosal studies showed that ARM significantly increased
the mucosal defensive factors like mucus secretion, cellular
mucus, life span of cells and also possessed significant anti-oxidant
effect, but had little or no effect on offensive factors like
acid and pepsin.
|
|
|
Department of Pharmacology, College of
Medical Sciences, University of Maiduguri. P.M.B. 1069, Maiduguri,
Nigeria.
The effect of methanolic extract of Asparagus
pubescens root on experimentally-induced diarrhoea and ulceration
was investigated in rats. The extract (500-1500 mg/kg) dose-dependently,
reduced significantly the intestinal propulsive movement,
castor oil-induced diarrhoea and intestinal fluid accumulation.
Yohimbine an alpha(2)-adrenoceptor blocker attenuated the
antidiarrhoeal effect of the extract. The extract also reduced
the ulcer indices induced by indomethacin and ethanol in
a dose-related manner. The results indicate that its antidiarrhoeal
and antiulcerogenic effects might in part be due to its
alpha(2)-adrenoceptor stimulation and its active constituents
respectively.
|
|
|
Cell Biology Division, Bhabha Atomic
Research Centre, 400 085, Mumbai, India.
The possible antioxidant effects of crude
extract and a purified aqueous fraction of Asparagus racemosus
against membrane damage induced by the free radicals generated
during gamma-radiation were examined in rat liver mitochondria.
gamma-Radiation, in the dose range of 75-900 Gy, induced
lipid peroxidation as assessed by the formation of thiobarbituric
acid reactive substances (TBARS) and lipid hydroperoxides
(LOOH). Using an effective dose of 450 Gy, antioxidant effects
of A. racemosus extract were studied against oxidative damage
in terms of protection against lipid peroxidation, protein
oxidation, depletion of protein thiols and the levels of
the antioxidant enzyme, superoxide dismutase. An active
fraction consisting of polysaccharides (termed as P3) was
effective even at a low concentration of 10 microg/ml. Both
the crude extract as well as the P3 fraction significantly
inhibited lipid peroxidation and protein oxidation. The
antioxidant effect of P3 fraction was more pronounced against
lipid peroxidation, as assessed by TBARS formation, while
that of the crude extract was more effective in inhibiting
protein oxidation. Both the crude extract and P3 fraction
also partly protects against radiation-induced loss of protein
thiols and inactivation of superoxide dismutase. The inhibitory
effects of these active principles, at the concentration
of 10 microg/ml, are comparable to that of the established
antioxidants glutathione and ascorbic acid. Hence our results
indicate that extracts from A. racemosus have potent antioxidant
properties in vitro in mitochondrial membranes of rat liver.
|
|
BEETS |
|
|
Department of Food Science, Institute
of Technology and Storage of Agricultural Products, Agricultural
Research Organization, P.O. Box 6, Bet Dagan 50250, Israel.
Antioxidant nutrients from fruits and vegetables
are believed to be a class of compounds that exert their
effects in humans by preventing oxidative processes which
contribute to the onset of several degenerative diseases.
This study found a new class of dietary cationized antioxidants
in red beets (Beta vulgaris L.). These antioxidants are
betalains, and the major one, betanin, is a betanidin 5-O-beta-glucoside.
Linoleate peroxidation by cytochrome c was inhibited by
betanin, betanidin, catechin, and alpha-tocopherol with
IC(50) values of 0.4, 0.8, 1.2, and 5 microM, respectively.
In addition, a relatively low concentration of betanin was
found to inhibit lipid peroxidation of membranes or linoleate
emulsion catalyzed by the "free iron" redox cycle,
H(2)O(2)-activated metmyoglobin, or lipoxygenase. The IC(50)
inhibition of H(2)O(2)-activated metmyoglobin catalysis
of low-density lipoprotein oxidation by betanin was <2.5
microM and better than that of catechin. Betanin and betanidin
at very small concentrations were found to inhibit lipid
peroxidation and heme decomposition. During this reaction,
betanidin was bleached completely, but betanin remained
unchanged in its absorption. This difference seems to derive
from differing mechanisms of protection by these two compounds.
The high affinity of betanin and betanidin for membranes
was demonstrated by determining the rate of migration of
the compounds through a dialysis tube. Betanin bioavailability
in humans was demonstrated with four volunteers who consumed
300 mL of red beet juice, containing 120 mg of the antioxidant.
The betacyanins were absorbed from the gut and identified
in urine after 2-4 h. The calculated amount of betacyanins
found in the urine was 0.5-0.9% of that ingested. Red beet
products used regularly in the diet may provide protection
against certain oxidative stress-related disorders in humans.
|
|
BROCCOLI |
|
|
Division of Carcinogenesis and
Molecular Epidemiology, American Health Foundation, Valhalla,
NY 10595, USA.
The cancer-chemopreventive effects
of broccoli may be attributed, in part, to isothiocyanates
(ITCs), hydrolysis products of glucosinolates. Glucosinolates
are hydrolyzed to their respective ITCs by the enzyme myrosinase,
which is inactivated by heat. In this study, the metabolic
fate of glucosinolates after ingestion of steamed and fresh
broccoli was compared in 12 male subjects in a crossover
design. During each 48-hour baseline period, no foods containing
glucosinolates or ITCs were allowed. The subjects then consumed
200 g of fresh or steamed broccoli; all other dietary sources
of ITCs were excluded. Blood and urine samples were collected
during the 24-hour period after broccoli consumption. Total
ITC equivalents in broccoli and total ITC equivalents in
plasma and urine were assayed by high-performance liquid
chromatography as the cyclocondensation product of 1,2-benzenedithiol.
The content of ITCs in fresh and steamed broccoli after
myrosinase treatment was found to be virtually identical
(1.1 vs. 1.0 micromol/g wet wt). The average 24-hour urinary
excretion of ITC equivalents amounted to 32.3 +/- 12.7%
and 10.2 +/- 5.9% of the amounts ingested for fresh and
steamed broccoli, respectively. Approximately 40% of total
ITC equivalents in urine, 25.8 +/- 13.9 and 6.9 +/- 2.5
micromol for fresh and steamed broccoli, respectively, occurred
as the N-acetyl-L-cysteine conjugate of sulforaphane (SFN-NAC).
Total ITC metabolites in plasma peaked between 0 and 8 hours,
whereas urinary excretion of total ITC equivalents and SFN-NAC
occurred primarily between 2 and 12 hours. Results of this
study indicate that the bioavailability of ITCs from fresh
broccoli is approximately three times greater than that
from cooked broccoli, in which myrosinase is inactivated.
Considering the cancer-chemopreventive potential of ITCs,
cooking broccoli may markedly reduce its beneficial effects
on health.
|
|
|
Department of Pharmacology and Molecular
Sciences, The Johns Hopkins University School of Medicine,
Baltimore, Maryland 21205, USA.
Broccoli sprouts are a rich source of glucosinolates
and isothiocyanates that induce phase 2 detoxication enzymes,
boost antioxidant status, and protect animals against chemically
induced cancer. Glucosinolates are hydrolyzed by myrosinase
(an enzyme found in plants and bowel microflora) to form
isothiocyanates. In vivo, isothiocyanates are conjugated
with glutathione and then sequentially metabolized to mercapturic
acids. These metabolites are collectively designated dithiocarbamates.
We studied the disposition of broccoli sprout glucosinolates
and isothiocyanates in healthy volunteers. Broccoli sprouts
were grown, processed, and analyzed for (a) inducer potency;
(b) glucosinolate and isothiocyanate concentrations; (c)
glucosinolate profiles; and (d) myrosinase activity. Dosing
preparations included uncooked fresh sprouts (with active
myrosinase) as well as homogenates of boiled sprouts that
were devoid of myrosinase activity and contained either
glucosinolates only or isothiocyanates only. In a crossover
study, urinary dithiocarbamate excretion increased sharply
after administration of broccoli sprout glucosinolates or
isothiocyanates. Cumulative excretion of dithiocarbamates
following 111-micromol doses of isothiocyanates was greater
than that after glucosinolates (88.9 +/- 5.5 and 13.1 +/-
1.9 micromol, respectively; P < 0.0003). In subjects
fed four repeated 50-micromol doses of isothiocyanates,
the intra- and intersubject variation in dithiocarbamate
excretion was very small (coefficient of variation, 9%),
and after escalating doses, excretion was linear over a
25- to 200-micromol dose range. Dithiocarbamate excretion
was higher when intact sprouts were chewed thoroughly rather
than swallowed whole (42.4 +/- 7.5 and 28.8 +/- 2.6 micromol;
P = 0.049). These studies indicate that isothiocyanates
are about six times more bioavailable than glucosinolates,
which must first be hydrolyzed. Thorough chewing of fresh
sprouts exposes the glucosinolates to plant myrosinase and
significantly increases dithiocarbamate excretion. These
findings will assist in the design of dosing regimens for
clinical studies of broccoli sprout efficacy.
|
|
|
Department of Nutrition and
Food Studies, New York University, 35 West 4th Street, 10th
Floor, New York, NY 10012-1172.
Cancer is the second leading cause of death
in the United States; it accounts for nearly one-fourth
of annual deaths. Although the rates of some cancers have
been declining, rates of others have increased. Thus, despite
advances in early detection and treatment, overall death
rates from cancer have remained largely unchanged since
the early 1970s, suggesting the need for a stronger research
focus on prevention. Approaches to prevention necessarily
include smoking cessation and dietary changes, because each
is believed to contribute to about one-third of annual cancer
deaths. For two decades, dietary advice to prevent cancer
has emphasized fruit and vegetable consumption, and recent
recommendations, such as those listed in Table 1, give highest
priority to consuming plant-based diets. Such advice is
entirely consistent with recommendations for prevention
of heart disease and other diet-related chronic diseases.
It is supported by substantial, increasing, and extensively
reviewed evidence linking intake of plant foods to impressive
reductions in cancer risk at several major sites. On the
basis of this evidence, researchers recently have estimated
that plant-based diets prevent 20% to 50% of all cases of
cancer.
Epidemiologic and animal studies have associated certain
food plants with pronounced reductions in cancer risk. Among
such plants are cruciferous (mustard family) vegetables
of the genus Brassica: broccoli, cabbage, cauliflower, and
Brussels sprouts, among others. National committees have
recommended consumption of these vegetables for cancer prevention
since the early 1980s. What characteristics of these vegetables
might protect against carcinogenesis? Fahey et al. directly
address this important question. Brassica vegetables contain
little fat, are low in energy, and are sources of vitamins,
minerals, and fiber—all aspects linked to cancer protection.
They also contain a large number of phytochemicals, some
of which protect against carcinogenesis in various in vitro
and animal testing systems.
The research of Fahey et al aims to identify specific phytochemicals
in Brassica vegetables that may confer protection and the
mechanisms by which they do so. The hypothesis underlying
this work is that certain phytochemicals might raise the
activity of enzyme systems that detoxify carcinogens. Several
enzyme systems oxidize, reduce, or hydrolyze (phase 1) and
then conjugate or otherwise affect (phase 2) drugs, metabolites,
carcinogens, and other toxic chemicals, thereby increasing
their polarity and excretability. Phase 1 enzymes activate
or deactivate carcinogens, depending on the experimental
conditions. Phase 2 enzymes are more likely to detoxify.
For 20 years or more, consumption of cruciferous vegetables
has been known to induce enzyme detoxification in experimental
systems. Such observations have led Paul Talalay and his
colleagues to conduct an elegant series of studies on the
effects of cruciferous vegetable extracts on phase 2 enzyme
induction and animal tumorigenesis. They have developed
an in vitro assay to distinguish bifunctional phytochemicals
that induce both phase 1 and phase 2 enzyme systems from
monofunctional phytochemicals that induce only phase 2 enzymes.
They then used this assay to demonstrate that Brassica vegetables
are particularly rich sources of monofunctional phase 2
inducers and to identify the isothiocyanate sulforaphane
as the principal phase 2 inducer in broccoli extracts. They
also have demonstrated that sulforaphane is a dose-related
inhibitor of carcinogen-induced mammary tumorigenesis in
rats.
These impressive accomplishments now have been extended
to identify phase 2 inducer activity in sprouts of broccoli
as well as in mature plants. Most of this activity derived
from the glucosinolate precursor of sulforaphane, glucoraphanin.
Because no net synthesis of phase 2 inducers occurs after
sprouting, their concentration decreases as the plant grows.
Extracts of broccoli sprouts contain 10–100 times
the phase 2 inducer activity of mature broccoli plants and
are more efficient inhibitors of rat tumorigenesis. In contrast,
mature broccoli also contains significant amounts of indole
compounds that induce phase 1 as well as phase 2 enzymes.
Thus, sprouts would appear to offer at least two anticarcinogenic
advantages over mature broccoli: they contain higher concentrations
of inducers, and the inducers mainly affect phase 2 enzyme
systems. On this basis, Fahey et al. conclude that small
amounts of cruciferous vegetable sprouts may be just as
protective against cancer as larger amounts of mature plants
of the same variety.
These studies leave no doubt that sulforaphane does indeed
induce phase 2 enzymes and inhibit carcinogenesis under
these conditions. At issue, however, is the clinical significance
of induction of such enzyme systems by single phytochemicals.
Both phase 1 and phase 2 systems are highly multifunctional
and inducible by a wide variety of dietary compounds. Food
plants have evolved to contain thousands of chemicals that
act as protective pesticides against infection or predation,
and humans may consume as many as 10,000 of these compounds
and their metabolic products when eating vegetables. The
Ames group has identified 49 such compounds in cabbage,
among them several that have been tested and found mutagenic
or carcinogenic in animal test systems. Table 2 identifies
the classes of phytochemicals in cruciferous vegetables
that contain at least one compound that has proved mutagenic
or carcinogenic in such tests. Thus, cruciferous and other
vegetables contain some phytochemicals that are carcinogenic
and others that are anticarcinogenic in test systems.
This confusing situation is complicated further by the ability
of both phase 1 and phase 2 enzyme systems to inactivate
some carcinogens, but activate others, depending on circumstances.
Chemicals that induce activating enzymes also will induce
activation of any other compounds present that are metabolized
by the same system; the same is true of substances that
induce inactivation. This dual nature of the enzyme systems,
the vast number of compounds that can induce them, the presence
in broccoli of chemicals that induce both activation and
inhibition of carcinogenesis, and the complexity of the
interactions among food phytochemicals and enzyme systems,
constitute the basis of ongoing debates as to whether sulforaphane
or any other single phytochemical or nutrient can explain
the cancer-protective effects of cruciferous vegetables.
Fortunately, the dietary implications of this work are less
complicated. The precise role in carcinogenesis of specific
vitamins, minerals, fiber, and phytochemicals may be uncertain,
but the overall anticarcinogenic properties of vegetables
clearly outweigh any effects of their constituent carcinogens
or carcinogen-inducers. The value of eating more vegetables
in general, and Brassica vegetables in particular, is well
supported by current evidence if for no other reason than
this food group is a principal source of antioxidant vitamins;
vegetables provide more than 80% of the carotene, 50% of
the vitamin C, and 25% of the folate in the American food
supply.
Dietary recommendations for prevention of cancer and other
chronic diseases always have emphasized the value of consuming
a variety of plant foods. Each vegetable contributes nutrients,
fiber, and phytochemicals, but in varying amounts and proportions.
Fahey et al found an 8-fold variation in phase 2 inducer
activity among different samples of fresh broccoli, a variation
that was independent of appearance or growing conditions.
Broccoli may be especially rich in sulforaphane, but tomatoes
are especially rich in lycopenes, peppers in carotenoids,
and onions and garlic in allium compounds—all demonstrably
protective against carcinogenesis.
President George Bush did not like broccoli; the mass appeal
of broccoli sprouts is even less certain. My local health
food store sells cruciferous sprouts of cabbage, radish,
and mustard, but not yet broccoli; broccoli sprouts taste
like milder versions of the mature vegetable and are slightly
pungent or peppery. The store does offer dessicated broccoli
in the form of 500-mg supplements labeled as containing
200 µg sulforaphane; 50 such tablets cost $14.70.
Price considerations aside, supplements confer little advantage.
Fresh vegetables provide a higher content of vitamin C,
folic acid, and fiber, and a balance of phytochemicals that
favor overall protection against carcinogenesis. The full
range of nutrients contained in foods must be present to
detoxify carcinogens; iron, niacin, and riboflavin, for
example, are essential cofactors in phase 1 and phase 2
enzyme systems. Just as single-nutrient approaches to cancer
prevention have yielded disappointing results, single phytochemical
approaches are likely to prove equally disappointing and
are not recommended.
The policy implications of this research also seem quite
straightforward. Policies are needed to promote consumption
of vegetables among a greater proportion of the population.
Recent data suggest that the average American consumes slightly
more than two standard half-cup servings of vegetables (other
than white potatoes) daily; at least 10% of the population
reports consuming less than one daily serving of any vegetable
whatsoever. Although broccoli and cabbage rank among the
top 10 vegetables purchased in supermarkets, and U.S. annual
production (though not necessarily consumption) of fresh
broccoli rose from 0.8 to 4.1 pounds per capita from 1973
to 1997, this quantity translates to just 5 g per day per
capita. Thus, the current situation leaves considerable
room for improvement. From the standpoint of public health
policy, existing data are more than sufficient to promote
greater consumption of broccoli and its sprouts along with
other vegetables. Educational campaigns to encourage fruit
and vegetable consumption have achieved some success, but
a greater range of policies and programs targeted to food
producers as well as to consumers might prove more effective
in raising consumption levels.
From the standpoint of cancer research policy, information
about the role of each nutrient and phytochemical is of
vital interest; such information may well explain why diet-related
cancer risks vary across different sites and among individuals
and populations. The effects of single anticarcinogenic
phytochemicals, however, no matter how well characterized,
cannot be understood in isolation, just as the anticarcinogenic
effects of single nutrients cannot be understood except
as part of an overall dietary pattern. Dietary patterns,
of course, are difficult to study. If research to date has
focused on the effects of isolated nutrients and phytochemicals,
it is because such systems are far more amenable to investigation.
Debates about the significance of the effects of sulforaphane
on cancer risk are best interpreted as evidence of the need
for high-quality research on the health effects of dietary
patterns and their determinants—behavioral, environmental,
economic, and cultural—as well as on the scientific
basis of these relationships.
|
|
BRUSSELS SPROUTS |
|
|
Department of Medicinal Chemistry
and Pharmacognosy, College of Pharmacy, University of Illinois
at Chicago 60612.
Cabbage, broccoli, Brussels sprouts, and
other members of the genus Brassica have been widely regarded
as potentially cancer preventative. This view is often based
on both experimental testing of crude extracts and epidemiological
data. The experimental evidence that provides support for
this possibility is reviewed for the commonly consumed varieties
of Brassica oleracea. In a majority of cases the biological
activities seen in testing crude extracts may be directly
related to specific chemicals that have been reported to
be isolated from one of these closely related species, thus
the chemical evidence further supports the data from testing
extracts and epidemiology.
|
|
|
Department of Pharmacology, University
of Copenhagen, Panum, Denmark.
The alleged cancer preventive effects of
cruciferous vegetables could be related to protection from
mutagenic oxidative DNA damage. We have studied the effects
of Brussels sprouts, some non-cruciferous vegetables and
isolated glucosinolates on spontaneous and induced oxidative
DNA damage in terms of 8-oxo-7,8-dihydro-2'-deoxyguanosine
(8-oxodG) in groups of 6-8 male Wistar rats. Excess oxidative
DNA damage was induced by 2-nitropropane (2-NP 100 mg/kg).
Four days oral administration of 3 g of cooked Brussels
sprouts homogenate reduced the spontaneous urinary 8-oxodG
excretion by 31% (p<0.05) whereas raw sprouts, beans
and endive (1:1), isolated indolyl glucosinolates and breakdown
products had no significant effect. An aqueous extract of
cooked Brussels sprouts (corresponding to 6.7 g vegetable
per day for 4 days) decreased the spontaneous 8-oxodG excretion
from 92 +/- 12 to 52 +/- 15 pmol/24 h (p<0.05). After
2-NP administration the 8-oxodG excretion was increased
to 132 +/- 26 pmol/24 h (p<0.05) whereas pretreatment
with the sprouts extract reduced this to 102 +/- 30 pmol/24
h (p<0.05). The spontaneous level of 8-oxodG in nuclear
DNA from liver and bone marrow was not significantly affected
by the sprouts extract whereas the level decreased by 27%
in the kidney (p<0.05). In the liver 2-NP increased the
8-oxodG levels in nuclear DNA 8.7 and 3.8 times (p<0.05)
6 and 24 h after dose, respectively. The sprouts extract
reduced this increase by 57% (p<0.05) at 6 h whereas
there was no significant effect at 24 h. In the kidneys
2-NP increased the 8-oxodG levels 2.2 and 1.2 times (p<0.05)
6 and 24 h after dose, respectively. Pretreatment with the
sprouts extract abolished these increases (p<0.05). Similarly,
in the bone marrow the extract protected completely (p<0.05)
against a 4.9-fold 2-NP induced increase (p<0.05) in
the 8-oxodG level. These findings demonstrate that cooked
Brussels sprouts contain bioactive substance(s) with a potential
for reducing the physiological as well as oxidative stress
induced oxidative DNA damage in rats. This could explain
the suggested cancer preventive effect of cruciferous vegetables.
The correspondence between the urinary excretion and 8-oxodG
levels in 2-NP target organs supports its being the main
repair product that reflects the rate of guanine oxidation
in DNA.
|
|
|
Department of Pharmacology and Molecular
Sciences, The Johns Hopkins University School of Medicine,
Baltimore, Maryland 21205, USA.
Broccoli sprouts are a rich source of glucosinolates
and isothiocyanates that induce phase 2 detoxication enzymes,
boost antioxidant status, and protect animals against chemically
induced cancer. Glucosinolates are hydrolyzed by myrosinase
(an enzyme found in plants and bowel microflora) to form
isothiocyanates. In vivo, isothiocyanates are conjugated
with glutathione and then sequentially metabolized to mercapturic
acids. These metabolites are collectively designated dithiocarbamates.
We studied the disposition of broccoli sprout glucosinolates
and isothiocyanates in healthy volunteers. Broccoli sprouts
were grown, processed, and analyzed for (a) inducer potency;
(b) glucosinolate and isothiocyanate concentrations; (c)
glucosinolate profiles; and (d) myrosinase activity. Dosing
preparations included uncooked fresh sprouts (with active
myrosinase) as well as homogenates of boiled sprouts that
were devoid of myrosinase activity and contained either
glucosinolates only or isothiocyanates only. In a crossover
study, urinary dithiocarbamate excretion increased sharply
after administration of broccoli sprout glucosinolates or
isothiocyanates. Cumulative excretion of dithiocarbamates
following 111-micromol doses of isothiocyanates was greater
than that after glucosinolates (88.9 +/- 5.5 and 13.1 +/-
1.9 micromol, respectively; P < 0.0003). In subjects
fed four repeated 50-micromol doses of isothiocyanates,
the intra- and intersubject variation in dithiocarbamate
excretion was very small (coefficient of variation, 9%),
and after escalating doses, excretion was linear over a
25- to 200-micromol dose range. Dithiocarbamate excretion
was higher when intact sprouts were chewed thoroughly rather
than swallowed whole (42.4 +/- 7.5 and 28.8 +/- 2.6 micromol;
P = 0.049). These studies indicate that isothiocyanates
are about six times more bioavailable than glucosinolates,
which must first be hydrolyzed. Thorough chewing of fresh
sprouts exposes the glucosinolates to plant myrosinase and
significantly increases dithiocarbamate excretion. These
findings will assist in the design of dosing regimens for
clinical studies of broccoli sprout efficacy.
|
|
CABBAGE |
|
|
Department of Applied Biological Science,
Tokyo Noko University, Tokyo 183-8509, Japan.
The effect of cabbage extract on
the production of tumor necrosis factor and its implication
in the antitumor effect were examined in vitro and in vivo.
Cabbage extract stimulated the production of tumor necrosis
factor by rat spleen cells and showed cytotoxic activity
in a rat ascites hepatoma cell line (AH109A) when hepatoma
cells were cultured with cabbage-stimulated spleen cells.
When the extract was adminstered orally to AH109A-bearing
rats in combination with lipopolysaccharide injection, the
hepatoma weights were reduced to one-half of the vehicle
control. The cytotoxic activity of tumor-infiltrating macrophages
was induced by simultaneous treatment with cabbage extract
and lipopolysaccharide. These results indicate that cabbage
extract contains macrophage-stimulating component(s) and
can implement the antitumor effect by stimulating the cytotoxicity
of tumor-infiltrating macrophages.
|
|
|
Department of Applied Biological Science,
Tokyo Noko University, Fuchu, Japan.
The effect of cabbage extract on cholesterol
metabolism was studied in Donryu rats subcutaneously implanted
with an ascites hepatoma cell line (AH109A). The hepatoma-bearing
rats exhibited hypercholesterolemia induced by increasing
cholesterogenesis in the host liver and decreasing steroid
excretion into feces. The cabbage extract intake or administration
reduced serum cholesterol level and enhanced fecal bile acid
excretion and cholesterol 7alpha-hydroxylase activity, the
rate-limiting enzyme of bile acid biosynthesis, in the microsomal
fraction of the liver. Furthermore, S-methyl-L-cysteine sulfoxide,
a component of cabbage, could mimic the effect of cabbage
extract when orally administered. These results suggest that
cabbage suppresses hypercholesterolemia responding to hepatoma
growth by upregulating cholesterol catabolism and that S-methyl-L-cysteine
sulfoxide in cabbage is one of the factors suppressing hypercholesterolemia
in the hepatoma-bearing rats.
|
|
|
Department of Bioresource Engineering,
Faculty of Agriculture, Yamagata University, Tsuruoka-shi,
Japan.
The preventive effects of acylated anthocyanins
from red cabbage on paraquat-induced oxidative stress were
determined in rats. Decreased food intake and body weight
gain, and increased lung weight and atherogenic index by
feeding the rats on a diet containing paraquat were clearly
suppressed by supplementing acylated anthocynins to the
paraquat diet. Paraquat feeding increased the concentration
of thiobarbituric acid-reactive substances (TBARS) in liver
lipids, and decreased the liver triacylglycerol level. These
effects tended to be suppressed by supplementing acylated
anthocynins to the paraquat diet. In addition, the catalase
activity in the liver mitochondrial fraction was markedly
decreased by feeding on the paraquat diet, this decrease
being partially suppressed by supplementing the paraquat
diet with acylated anthocyanins. An increase in the NADPH-cytochrome-P450-reductase
activity in the liver microsome fraction by paraquat was
suppressed by supplementing the paraquat diet with acylated
anthocyanins. These results suggest that acylated anthocyanins
from red cabbage acted preventively against the oxidative
stress in vivo that may have been due to active oxygen species
formed through the action of paraquat.
|
|
|
Interest in the potential of cabbage
and other Brassica species as possible dietary cancer-inhibitors
has been expressed. Preliminary data in support of this
include the following: dietary cabbage has been reported
to enhance the aromatic hydrocarbon hydroxylase (AHH) microsomal
enzyme system and increase the rate of metabolism of certain
drugs and carcinogens and to affect chemically-induced tumor
formation. Bacterial studies also indicate that cabbage
has demutagenic activity in the Ames assay. Cabbage has
also been reported to have a protective effect against radiation
exposure. In addition, cabbage has been shown to have a
variable ability to induce goiter formation in otherwise
healthy laboratory animals. Other effects discussed in the
literature include an affect on blood sugar, gastric secretion
and antibacterial activity. Reference is made to claims
found in ancient herbal literature regarding cabbage's alleged
therapeutic benefit in putatively cancerous conditions.
|
|
|
A randomized, controlled trial was
conducted to evaluate the effect of cabbage leaves on mothers'
perceptions of breast engorgement and the influence of this
treatment on breastfeeding practices. The subjects, 120
breastfeeding women 72 hours postpartum, were randomly allocated
to an experimental group who received application of cabbage
leaves to their breasts, or to a control group who received
routine care. The experimental group tended to report less
breast engorgement, but this trend was not statistically
significant. At six weeks, women who received the cabbage
leaf application were more likely to be breastfeeding exclusively,
76 and 58 percent (35/46 vs 29/50; P = 0.09), and their
mean duration of exclusive breastfeeding was longer (36
vs 30 days; P = 0.04). The greater breastfeeding success
in the experimental group may have been due to some beneficial
effect of cabbage leaf application, or may have been secondary
to reassurance and improved confidence and self-esteem in
these mothers.
|
|
CARROTS |
|
|
Institut fur Pharmakognosie der
Universitat Wien, Althanstrasse 14, A-1090 Wien.
Adherence of microorganisms to the intestinal mucosa is an
important and initial step in the pathogenesis of gastrointestinal
infections and mediated by carbohydrate structures on the
cell surface. Adherence can be blocked by carbohydrate receptor
analogues. Aqueous extracts from carrots (carrot soup) contain
acidic oligosaccharides, which are able to block adherence
of various enteropathogenic microorganisms to HEp-2 cells
and human intestinal mucosa in vitro. Dependent on the grade
of polymerisation the most potent blocking ability was seen
for trigalacturonic acid. Clinical studies revealed, that
aqueous carrot extracts are significantly superior to the
basic glucose-electrolyt-solution for oral rehydration in
acute gastrointestional infections of children.
|
|
|
Allergy Unit, Department of Dermatology,
University Hospital, Zurich, Switzerland.
BACKGROUND: Allergic reactions to carrot
affect up to 25% of food-allergic subjects. Clinical manifestations
of carrot allergy and IgE responses to carrot proteins,
however, have never been studied in subjects with carrot
allergy confirmed by means of double-blinded, placebo-controlled
food challenge (DBPCFC). OBJECTIVE: The purposes of this
investigation were to confirm clinically relevant sensitizations
to carrot by means of DBPCFC, to validate current diagnostic
methods, and to identify IgE-reactive carrot proteins in
patients with true allergy. METHODS: DBPCFCs were performed
in 26 subjects with histories of allergic reactions to carrot.
Patients underwent skin prick tests with carrot extract,
fresh carrot, and various pollen extracts. Specific IgE
to carrot, celery, birch, and mugwort pollen and to rBet
v 1, rBet v 2, and rBet v 6 were measured through use of
the CAP method. Carrot allergens were identified by means
of immunoblotting and blotting inhibition. RESULTS: Twenty
of 26 patients had positive DBPCFC results. The sensitivity
of the determination of carrot-specific IgE antibodies through
use of the CAP method (> or =0.7 kU/L) was 90%, the sensitivity
for skin prick testing with commercial extracts was 26%,
and the sensitivity for prick-to-prick tests with raw carrot
was 100%. The Bet v 1--related major carrot allergen Dau
c 1 was recognized by IgE from 85% of patients; 45% were
sensitized to cross-reactive carbohydrate determinants and
20% to carrot profilin. In 1 subject, a Bet v 6--related
carrot allergen was recognized. In 4 patients, IgE binding
to Dau c 1 was not inhibited or was weakly inhibited by
rBet v 1 or birch pollen extract. CONCLUSION: This study
confirmed the allergenicity of carrot by means of DBPCFC.
DBPCFC-positive patients had exclusively specific IgE antibodies
to birch pollen--related carrot allergens, Dau c 1 being
the major allergen. The lack of inhibition of IgE binding
to Dau c 1 by birch allergens in a subgroup of patients
might indicate an secondary immune response to new epitopes
on the food allergen that are not cross-reactive with Bet
v 1.
|
|
|
Food Research Center, University of Lincolnshire
and Humberside, Brayford Pool, Lincoln LN6 7TS, United Kingdom.
Four different colored carrots, orange,
purple with orange core, yellow, and white, were examined
for their content of phenolics, antioxidant vitamins, and
sugars as well as their volatiles and sensory responses.
A total of 35 volatiles were identified in all carrots,
27 positively. White carrot contained the highest content
of volatiles, followed by orange, purple, and yellow. In
total, 11, 16, 10, and 9 phenolic compounds were determined
for the first time in orange, purple, yellow, and white
carrots, respectively. Of these, chlorogenic acid was the
most predominant phenolic compound in all carrot varieties.
Differences (p < 0.05) in relative sweetness, the contents
of vitamin C and alpha- and beta-carotenes, and certain
flavor characteristics were observed among the colored carrot
varieties examined. Purple carrots contained 2.2 and 2.3
times more alpha- and beta-carotenes (trace in yellow; not
detected in white) than orange carrots, respectively. Purple
carrot may be used in place of other carrot varieties to
take advantage of its nutraceutical components.
|
|
|
Department of Physiology and Pharmacology,
The Aga Khan University Medical College, Karachi, Pakistan.
Daucus carota (carrot) has been used
in traditional medicine to treat hypertension. Activity-directed
fractionation of aerial parts of D. carota resulted in the
isolation of two cumarin glycosides coded as DC-2 and DC-3.
Intravenous administration of these compounds caused a dose-dependent
(1-10 mg/kg) fall in arterial blood pressure in normotensive
anaesthetised rats. In the in vitro studies, both compounds
caused a dose-dependent (10-200 microg/ml) inhibitory effect
on spontaneously beating guinea pig atria as well as on
the K+ -induced contractions of rabbit aorta at similar
concentrations. These results indicate that DC-2 and DC-3
may be acting through blockade of calcium channels and this
effect may be responsible for the blood pressure lowering
effect of the compounds observed in the in vivo studies.
|
|
|
Groupe de Physiopathologie Digestive
et Nutritionnelle, Hopital Charles Nicolle, Rouen, France.
The aim of the present study was to assess,
in healthy volunteers and under physiological conditions,
the acceptability, clinical tolerance and effects on colonic
motility of chronic supplementation of the usual diet with
new dietary fibre sources. Three studies were carried out,
one after a period of habitual diet, and two after randomized
3-week periods of supplementation with fibre extracted either
from pea hulls or carrots, added to the meals as a fine
powder. The 24 h motility was recorded on an unprepared
colon at five levels to determine the initiation site and
the number of high amplitude propagated contractions (HAPC)
and to quantify motor activity every 30 min, particularly
in the two periods following lunch and breakfast. With the
habitual diet the motility pattern was an irregular alternation
of quiescence and sporadic non-propagated contractions.
HAPC always started from the ascending colon and occurred
mainly after breakfast. With either type of fibre the 24
h motor profiles, the 24 h variations and the number of
HAPC were not significantly modified but a more distal initiation
of HAPC was found. The colonic postprandial motor response
was more diffuse after dietary enrichment with carrot fibre
than after enrichment with pea-hull fibre. In healthy volunteers
the long-term addition of fibre extracted from pea hulls
and carrots to the usual diet was easy and well-tolerated
without clinical side-effects, but with limited colonic
motor effects. However, the more distal initiation of HAPC
observed could be deleterious.
|
|
|
Department of Nutrition, National
Research Center, Giza, Dokki, Egypt.
Changes in plasma retinol and carotenoids
was measured in 17 young males after daily ingestion of
grated carrots, carrot juice or spinach leaves for 2 weeks.
Regression equations showed that the supply of 3350 and
4750 micrograms carotenes from 78 ml carrot juice (prepared
from 185 g carrots) or 91 g grated carrots, respectively
were adequate in maintaining plasma retinol at a constant
level in subjects with initial plasma retinol of 1.2 mumol/l.
Under similar experimental conditions, 280 g boiled spinach
leaves providing 12,700 micrograms carotenes were required
to maintain plasma retinol at a constant level. Apparent
carotene digestibilities of 47 and 81% were obtained with
carrot and spinach, respectively.
|
|
CAULIFLOWER |
|
|
Research Group on Quality, Safety
and Bioactivity of Plan Foods, Department of Food Science
and Technology, CEBAS-CSIC, P. O. Box 4195, Murcia 30080,
Spain.
The present study reports the development
of two extraction protocols, with potential industrial applicability,
to valorize cauliflower (Brassica oleracea L. var. botrytis)
byproducts as a source of antioxidant phenolics. In addition,
the nonionic polystyrene resin Amberlite XAD-2 was used
to obtain purified extracts. The extract yield, phenolic
content, phenolic yield, and correlation between the antioxidant
activity and the phenolic content were studied. The water
and ethanol protocols yield a phenolic content of 33.8 mg/g
freeze-dried extract and 62.1 mg/g freeze-dried extract,
respectively. This percentage increased considerably when
the extracts were purified using Amberlite XAD-2 yielding
a phenolic content of 186 mg/g freeze-dried extract (water
extract) and 311.1 mg/g freeze-dried extract (ethanol extract).
Cauliflower byproduct extracts showed significant free radical
scavenging activity (vs both DPPH(*) and ABTS(*)(+) radicals),
ferric reducing ability (FRAP assay), and capacity to inhibit
lipid peroxidation (ferric thiocyanate assay). In addition,
the antioxidant activity was linearly correlated with the
phenolics content. The results obtained indicate that the
cauliflower byproducts are a cheap source of antioxidant
phenolics very interesting from both the industrial point
of view and the possible usefulness as ingredients to functionalize
foodstuffs.
|
|
CHARD |
|
|
Department of Pharmacology, Faculty of
Pharmacy, Marmara University, 81010, Istanbul, Turkey.
In diabetes mellitus, increased free radical
formation raises the incidence of atherosclerosis and cardiovascular
diseases. Regardless of the type of diabetes, the objective
of the therapy is to achieve normoglycemia and to prevent
or delay the complications. Chard (Beta vulgaris L. var.
cicla) is used as a hypoglycemic agent by diabetic patients
in Turkey. The aim of this study was to investigate the
effect of feeding chard on diabetes-induced free radical-
mediated injury in rat aorta and heart tissues. Female Swiss
albino rats were randomly divided into four groups: control,
diabetic, chard, and diabetic + chard. Rats were subjected
to intraperitoneal streptozotocin (STZ, 65 mg/kg) to induce
diabetes. Chard extract (2 g/kg) was given for 28 days beginning
on the 14th day of the study. Aorta and heart tissue lipid
peroxidation and glutathione levels as well as blood glucose
levels were determined. The results of the present study
indicate that lipid peroxidation was increased and glutathione
levels were decreased in both aorta and heart tissue of
the diabetic rats. However, treatment with chard extract
reversed the effects of diabetes on blood glucose and tissue
lipid peroxidation and glutathione levels.
|
|
|
Department of Chemistry, Faculty of Engineering,
Istanbul University, 34850-Avcilar, Istanbul, Turkey.
The aim of this work was to investigate
the effects of chard (Beta vulgaris L. var. cicla) extract
on serum urea and creatinine concentrations and on kidney
tissue in normal and streptozotocin-diabetic rats. The extract
was administered to rats at a dose of 2 g/kg every day for
28 days, 14 days after animals were made diabetic. On day
42, kidney tissue and blood samples were examined. Significant
degenerative changes in kidney tissue of diabetic rats were
observed, but in the group given chard extract, the morphology
of kidney tissue was found to be nearly the same as the
controls. Serum urea and creatinine levels significantly
increased in the diabetic groups, but the chard extracts
significantly reduced serum urea and creatinine levels.
It is concluded that the extract of this plant may reduce
serum urea and creatinine levels and confer a protective
effect on the kidney of diabetic rats.
|
|
|
Department of Biochemistry, Faculty of
Dentistry, Marmara University, Nisantasi, Turkey.
Chard (Beta vulgaris L. var. cicla) is
one of the plants used as hypoglycaemic agent by diabetics
in Turkey and it has been reported to reduce blood glucose.
The purpose of this study was to investigate the effect
of feeding chard on diabetes induced impairments in rat
skins. Uncontrolled induced diabetes caused significant
increases in nonenzymatic glycosylation of skin proteins,
lipid peroxidation and blood glucose. Administration of
chard extract inhibited these effects except the increase
in lipid peroxidation. SDS-polyacrylamide gel electrophoresis
revealed no significant differences in any protein bands
between any of the groups. The data indicate that the use
of chard may be effective in preventing or at least retarding
the development of some diabetic complications.
|
|
CORN |
|
|
Division of Endocrinology, Diabetes and
Metabolism, Washington University, St Louis, MO 63110, USA.
BACKGROUND: Although supplementing the
diet with large quantities of phytosterols reduces cholesterol
absorption and LDL-cholesterol concentrations, very little
is known about the smaller amounts of phytosterols present
naturally in food. Vegetable oils are the richest dietary
source of phytosterols; corn oil contains 0.77% phytosterols
by weight. OBJECTIVE: We tested the hypothesis that removing
phytosterols from corn oil would increase cholesterol absorption
when measured in sing | | |